nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—RET—parathyroid gland—mediastinal cancer	0.0493	0.0629	CbGeAlD
Ponatinib—RET—Posttranslational regulation of adherens junction stability and dissassembly—PTPN1—mediastinal cancer	0.0292	0.135	CbGpPWpGaD
Ponatinib—FGFR4—hematopoietic system—mediastinal cancer	0.0237	0.0302	CbGeAlD
Ponatinib—KDR—Signaling events mediated by TCPTP—PTPN1—mediastinal cancer	0.018	0.0834	CbGpPWpGaD
Ponatinib—LYN—Growth hormone receptor signaling—PTPN1—mediastinal cancer	0.0176	0.0812	CbGpPWpGaD
Ponatinib—LYN—hematopoietic system—mediastinal cancer	0.0162	0.0207	CbGeAlD
Ponatinib—FGFR3—hematopoietic system—mediastinal cancer	0.0161	0.0206	CbGeAlD
Ponatinib—RET—neck—mediastinal cancer	0.0149	0.0191	CbGeAlD
Ponatinib—FGFR3—bronchus—mediastinal cancer	0.0145	0.0185	CbGeAlD
Ponatinib—FGFR1—N-cadherin signaling events—PTPN1—mediastinal cancer	0.0144	0.0668	CbGpPWpGaD
Ponatinib—FGFR2—neck—mediastinal cancer	0.0142	0.0181	CbGeAlD
Ponatinib—BCR—hematopoietic system—mediastinal cancer	0.014	0.0178	CbGeAlD
Ponatinib—FLT3—hematopoietic system—mediastinal cancer	0.0139	0.0177	CbGeAlD
Ponatinib—FGFR4—lung—mediastinal cancer	0.0137	0.0175	CbGeAlD
Ponatinib—BCR—bronchus—mediastinal cancer	0.0126	0.016	CbGeAlD
Ponatinib—SRC—Integrin alphaIIb beta3 signaling—PTPN1—mediastinal cancer	0.0116	0.0536	CbGpPWpGaD
Ponatinib—LYN—lymphoid tissue—mediastinal cancer	0.0114	0.0146	CbGeAlD
Ponatinib—BCR—trachea—mediastinal cancer	0.0113	0.0144	CbGeAlD
Ponatinib—FGFR1—bronchus—mediastinal cancer	0.0112	0.0143	CbGeAlD
Ponatinib—KDR—neck—mediastinal cancer	0.0111	0.0142	CbGeAlD
Ponatinib—RET—hematopoietic system—mediastinal cancer	0.0111	0.0142	CbGeAlD
Ponatinib—BCR—cardiac atrium—mediastinal cancer	0.0106	0.0135	CbGeAlD
Ponatinib—FGFR2—hematopoietic system—mediastinal cancer	0.0106	0.0135	CbGeAlD
Ponatinib—TEK—hematopoietic system—mediastinal cancer	0.0101	0.0129	CbGeAlD
Ponatinib—ABL1—Posttranslational regulation of adherens junction stability and dissassembly—PTPN1—mediastinal cancer	0.01	0.0464	CbGpPWpGaD
Ponatinib—LCK—bronchus—mediastinal cancer	0.01	0.0128	CbGeAlD
Ponatinib—KIT—neck—mediastinal cancer	0.00986	0.0126	CbGeAlD
Ponatinib—BCR—lymphoid tissue—mediastinal cancer	0.00983	0.0125	CbGeAlD
Ponatinib—FLT3—lymphoid tissue—mediastinal cancer	0.00976	0.0125	CbGeAlD
Ponatinib—LYN—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.00946	0.0438	CbGpPWpGaD
Ponatinib—FGFR1—cardiac atrium—mediastinal cancer	0.00944	0.012	CbGeAlD
Ponatinib—FGFR4—lymph node—mediastinal cancer	0.0094	0.012	CbGeAlD
Ponatinib—FGFR3—lung—mediastinal cancer	0.00937	0.012	CbGeAlD
Ponatinib—PDGFRA—hematopoietic system—mediastinal cancer	0.00918	0.0117	CbGeAlD
Ponatinib—TEK—bronchus—mediastinal cancer	0.00912	0.0116	CbGeAlD
Ponatinib—SRC—Platelet Aggregation (Plug Formation)—PTPN1—mediastinal cancer	0.00902	0.0417	CbGpPWpGaD
Ponatinib—SRC—hematopoietic system—mediastinal cancer	0.009	0.0115	CbGeAlD
Ponatinib—LCK—trachea—mediastinal cancer	0.00899	0.0115	CbGeAlD
Ponatinib—BCR—bone marrow—mediastinal cancer	0.00895	0.0114	CbGeAlD
Ponatinib—BCR—thyroid gland—mediastinal cancer	0.00893	0.0114	CbGeAlD
Ponatinib—FLT3—bone marrow—mediastinal cancer	0.00889	0.0113	CbGeAlD
Ponatinib—SRC—Signaling events mediated by TCPTP—PTPN1—mediastinal cancer	0.00847	0.0392	CbGpPWpGaD
Ponatinib—KDR—hematopoietic system—mediastinal cancer	0.00828	0.0106	CbGeAlD
Ponatinib—BCR—lung—mediastinal cancer	0.00811	0.0103	CbGeAlD
Ponatinib—FLT3—lung—mediastinal cancer	0.00805	0.0103	CbGeAlD
Ponatinib—FGFR1—thyroid gland—mediastinal cancer	0.00795	0.0101	CbGeAlD
Ponatinib—RET—lymphoid tissue—mediastinal cancer	0.00783	0.00999	CbGeAlD
Ponatinib—LCK—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.00776	0.0359	CbGpPWpGaD
Ponatinib—TEK—cardiac atrium—mediastinal cancer	0.00769	0.00981	CbGeAlD
Ponatinib—KDR—bronchus—mediastinal cancer	0.00745	0.00951	CbGeAlD
Ponatinib—PDGFRA—trachea—mediastinal cancer	0.00742	0.00946	CbGeAlD
Ponatinib—KIT—hematopoietic system—mediastinal cancer	0.00734	0.00936	CbGeAlD
Ponatinib—SRC—Posttranslational regulation of adherens junction stability and dissassembly—PTPN1—mediastinal cancer	0.00732	0.0339	CbGpPWpGaD
Ponatinib—FGFR1—lung—mediastinal cancer	0.00722	0.00921	CbGeAlD
Ponatinib—TEK—lymphoid tissue—mediastinal cancer	0.00713	0.0091	CbGeAlD
Ponatinib—LCK—bone marrow—mediastinal cancer	0.00713	0.0091	CbGeAlD
Ponatinib—LCK—thyroid gland—mediastinal cancer	0.00711	0.00907	CbGeAlD
Ponatinib—RET—thyroid gland—mediastinal cancer	0.00711	0.00907	CbGeAlD
Ponatinib—SRC—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.00687	0.0318	CbGpPWpGaD
Ponatinib—SRC—cardiac atrium—mediastinal cancer	0.00683	0.00872	CbGeAlD
Ponatinib—FGFR2—thyroid gland—mediastinal cancer	0.00676	0.00862	CbGeAlD
Ponatinib—KDR—trachea—mediastinal cancer	0.00669	0.00854	CbGeAlD
Ponatinib—KIT—bronchus—mediastinal cancer	0.0066	0.00843	CbGeAlD
Ponatinib—TEK—thyroid gland—mediastinal cancer	0.00648	0.00826	CbGeAlD
Ponatinib—PDGFRA—lymphoid tissue—mediastinal cancer	0.00646	0.00824	CbGeAlD
Ponatinib—LCK—lung—mediastinal cancer	0.00646	0.00824	CbGeAlD
Ponatinib—ABL1—hematopoietic system—mediastinal cancer	0.00639	0.00815	CbGeAlD
Ponatinib—SRC—lymphoid tissue—mediastinal cancer	0.00634	0.00808	CbGeAlD
Ponatinib—KDR—cardiac atrium—mediastinal cancer	0.00629	0.00802	CbGeAlD
Ponatinib—FGFR2—lung—mediastinal cancer	0.00614	0.00783	CbGeAlD
Ponatinib—KIT—trachea—mediastinal cancer	0.00593	0.00757	CbGeAlD
Ponatinib—TEK—lung—mediastinal cancer	0.00588	0.00751	CbGeAlD
Ponatinib—PDGFRA—thyroid gland—mediastinal cancer	0.00587	0.00749	CbGeAlD
Ponatinib—KDR—lymphoid tissue—mediastinal cancer	0.00583	0.00744	CbGeAlD
Ponatinib—SRC—thyroid gland—mediastinal cancer	0.00576	0.00734	CbGeAlD
Ponatinib—ABL1—bronchus—mediastinal cancer	0.00575	0.00734	CbGeAlD
Ponatinib—BCR—lymph node—mediastinal cancer	0.00555	0.00708	CbGeAlD
Ponatinib—FLT3—lymph node—mediastinal cancer	0.00551	0.00703	CbGeAlD
Ponatinib—PDGFRA—lung—mediastinal cancer	0.00533	0.0068	CbGeAlD
Ponatinib—KDR—bone marrow—mediastinal cancer	0.00531	0.00677	CbGeAlD
Ponatinib—KDR—thyroid gland—mediastinal cancer	0.00529	0.00675	CbGeAlD
Ponatinib—SRC—lung—mediastinal cancer	0.00523	0.00667	CbGeAlD
Ponatinib—KIT—lymphoid tissue—mediastinal cancer	0.00517	0.00659	CbGeAlD
Ponatinib—ABL1—trachea—mediastinal cancer	0.00516	0.00659	CbGeAlD
Ponatinib—SRC—Leptin signaling pathway—PTPN1—mediastinal cancer	0.00512	0.0237	CbGpPWpGaD
Ponatinib—FGFR1—lymph node—mediastinal cancer	0.00494	0.0063	CbGeAlD
Ponatinib—SRC—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—PTPN1—mediastinal cancer	0.00487	0.0225	CbGpPWpGaD
Ponatinib—ABL1—cardiac atrium—mediastinal cancer	0.00485	0.00619	CbGeAlD
Ponatinib—KDR—lung—mediastinal cancer	0.00481	0.00614	CbGeAlD
Ponatinib—KIT—bone marrow—mediastinal cancer	0.0047	0.006	CbGeAlD
Ponatinib—LYN—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.00469	0.0217	CbGpPWpGaD
Ponatinib—KIT—thyroid gland—mediastinal cancer	0.00469	0.00599	CbGeAlD
Ponatinib—ABL1—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.00467	0.0216	CbGpPWpGaD
Ponatinib—ABL1—lymphoid tissue—mediastinal cancer	0.0045	0.00574	CbGeAlD
Ponatinib—LCK—lymph node—mediastinal cancer	0.00442	0.00564	CbGeAlD
Ponatinib—RET—lymph node—mediastinal cancer	0.00442	0.00564	CbGeAlD
Ponatinib—KIT—lung—mediastinal cancer	0.00426	0.00544	CbGeAlD
Ponatinib—CYP2C8—hematopoietic system—mediastinal cancer	0.00414	0.00529	CbGeAlD
Ponatinib—ABL1—bone marrow—mediastinal cancer	0.00409	0.00522	CbGeAlD
Ponatinib—ABL1—thyroid gland—mediastinal cancer	0.00408	0.00521	CbGeAlD
Ponatinib—TEK—lymph node—mediastinal cancer	0.00402	0.00513	CbGeAlD
Ponatinib—TEK—Hemostasis—PTPN1—mediastinal cancer	0.00395	0.0183	CbGpPWpGaD
Ponatinib—LCK—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.00385	0.0178	CbGpPWpGaD
Ponatinib—CYP3A5—hematopoietic system—mediastinal cancer	0.00374	0.00477	CbGeAlD
Ponatinib—ABL1—lung—mediastinal cancer	0.00371	0.00473	CbGeAlD
Ponatinib—PDGFRA—lymph node—mediastinal cancer	0.00365	0.00465	CbGeAlD
Ponatinib—SRC—lymph node—mediastinal cancer	0.00358	0.00456	CbGeAlD
Ponatinib—SRC—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.0034	0.0157	CbGpPWpGaD
Ponatinib—KDR—lymph node—mediastinal cancer	0.00329	0.0042	CbGeAlD
Ponatinib—LYN—Platelet activation, signaling and aggregation—PTPN1—mediastinal cancer	0.00297	0.0138	CbGpPWpGaD
Ponatinib—KIT—lymph node—mediastinal cancer	0.00291	0.00372	CbGeAlD
Ponatinib—CYP3A4—hematopoietic system—mediastinal cancer	0.00281	0.00358	CbGeAlD
Ponatinib—CYP2D6—hematopoietic system—mediastinal cancer	0.00276	0.00352	CbGeAlD
Ponatinib—ABCG2—bone marrow—mediastinal cancer	0.00258	0.00329	CbGeAlD
Ponatinib—ABCG2—thyroid gland—mediastinal cancer	0.00258	0.00329	CbGeAlD
Ponatinib—ABL1—lymph node—mediastinal cancer	0.00254	0.00324	CbGeAlD
Ponatinib—LYN—Cytokine Signaling in Immune system—PTPN1—mediastinal cancer	0.00246	0.0114	CbGpPWpGaD
Ponatinib—LCK—Platelet activation, signaling and aggregation—PTPN1—mediastinal cancer	0.00244	0.0113	CbGpPWpGaD
Ponatinib—ABCG2—lung—mediastinal cancer	0.00234	0.00298	CbGeAlD
Ponatinib—CYP3A5—lung—mediastinal cancer	0.00217	0.00277	CbGeAlD
Ponatinib—SRC—Platelet activation, signaling and aggregation—PTPN1—mediastinal cancer	0.00216	0.00998	CbGpPWpGaD
Ponatinib—LCK—Cytokine Signaling in Immune system—PTPN1—mediastinal cancer	0.00202	0.00933	CbGpPWpGaD
Ponatinib—ABCB1—hematopoietic system—mediastinal cancer	0.00199	0.00253	CbGeAlD
Ponatinib—FGFR4—Immune System—PTPN1—mediastinal cancer	0.00193	0.00891	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—PTPN1—mediastinal cancer	0.00177	0.00818	CbGpPWpGaD
Ponatinib—ABCB1—trachea—mediastinal cancer	0.00161	0.00205	CbGeAlD
Ponatinib—ABCG2—lymph node—mediastinal cancer	0.0016	0.00204	CbGeAlD
Ponatinib—LYN—Hemostasis—PTPN1—mediastinal cancer	0.00153	0.00709	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—PTPN1—mediastinal cancer	0.00153	0.00706	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—PTPN1—mediastinal cancer	0.00143	0.00659	CbGpPWpGaD
Ponatinib—ABCB1—lymphoid tissue—mediastinal cancer	0.0014	0.00178	CbGeAlD
Ponatinib—ABCB1—bone marrow—mediastinal cancer	0.00127	0.00162	CbGeAlD
Ponatinib—ABCB1—thyroid gland—mediastinal cancer	0.00127	0.00162	CbGeAlD
Ponatinib—LCK—Hemostasis—PTPN1—mediastinal cancer	0.00126	0.00581	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—PTPN1—mediastinal cancer	0.00125	0.00576	CbGpPWpGaD
Ponatinib—ABCB1—lung—mediastinal cancer	0.00115	0.00147	CbGeAlD
Ponatinib—SRC—Hemostasis—PTPN1—mediastinal cancer	0.00111	0.00514	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—PTPN1—mediastinal cancer	0.00098	0.00453	CbGpPWpGaD
Ponatinib—KIT—Immune System—PTPN1—mediastinal cancer	0.000963	0.00445	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—PTPN1—mediastinal cancer	0.000922	0.00426	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—PTPN1—mediastinal cancer	0.000914	0.00423	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—PTPN1—mediastinal cancer	0.000911	0.00421	CbGpPWpGaD
Ponatinib—LYN—Immune System—PTPN1—mediastinal cancer	0.000804	0.00372	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—PTPN1—mediastinal cancer	0.000803	0.00371	CbGpPWpGaD
Ponatinib—ABL1—Immune System—PTPN1—mediastinal cancer	0.0008	0.0037	CbGpPWpGaD
Ponatinib—ABCB1—lymph node—mediastinal cancer	0.000789	0.00101	CbGeAlD
Ponatinib—LCK—Immune System—PTPN1—mediastinal cancer	0.000659	0.00305	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—PTPN1—mediastinal cancer	0.000634	0.00293	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—PTPN1—mediastinal cancer	0.000622	0.00288	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—PTPN1—mediastinal cancer	0.000591	0.00273	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—PTPN1—mediastinal cancer	0.000589	0.00272	CbGpPWpGaD
Ponatinib—SRC—Immune System—PTPN1—mediastinal cancer	0.000583	0.0027	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—PTPN1—mediastinal cancer	0.00052	0.0024	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—PTPN1—mediastinal cancer	0.000426	0.00197	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—PTPN1—mediastinal cancer	0.000377	0.00174	CbGpPWpGaD
